COMMUNIQUÉS West-GlobeNewswire
-
23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs
25/08/2026 -
Genmab to Participate in Upcoming Investor Conferences
25/08/2026 -
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
25/08/2026 -
Olympia Pharmaceuticals Introduces Polidocanol 2% Injection for Targeted Cosmetic Vein Treatment
25/08/2026 -
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
25/08/2026 -
Applied Biologics Announces Acceptance of Updated CAMPX XWRAP® Clinical Trial Results for Presentation at SAWC Fall 2026
25/08/2026 -
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
25/08/2026 -
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
25/08/2026 -
Polaryx Therapeutics Advances Operational Readiness for SOTERIA Phase 2 Basket Trial
25/08/2026 -
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
25/08/2026 -
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
25/08/2026 -
Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders
25/08/2026 -
Trading in GN Store Nord shares by board members, executives and associated persons
25/08/2026 -
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
25/08/2026 -
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
25/08/2026 -
4DMT to Participate in Upcoming Investor Conferences
25/08/2026 -
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
25/08/2026 -
Nu-Tek BioSciences participera au salon BPI East 2026 à Boston pour établir des liens entre ses nutriments pour milieux de culture sans composants d’origine animale et les stratégies de croissance de ses clients du secteur pharmaceutique
25/08/2026 -
Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies
25/08/2026
Pages